Abiopharma

Nucor Announces Guidance for the Second Quarter of 2026 Earnings

Venture Global and EnBW Announce New LNG Purchase Agreements

Postponement and Re-scheduling of Annual General Meeting

Legend Biotech Corporation Announces Proposed Public Offering

Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome

North Dallas Bank & Trust Co. Declares Regular Dividend

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

Other Report or Announcement

Verra Mobility Announces Organizational Changes to Accelerate Transformation and Enhance Customer Focus

Collective Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 22, 2026